The company will deliver its next generation product that includes both Dexcom CGM and Insulet's OmniPod pump data this summer.
The company uses certified diabetes educators (CDE) to reach users via phone calls, texts, emails and other mediums.
Ascensia Diabetes Care and Glooko teamed-up to bring together their state-of-the-art diabetes management solutions.
The non-exclusive collaboration will combine Novo Nordisk's deep knowledge of diabetes with Glooko's digital platform and data analytics expertise.
With the addition of DreaMed's Advisor in Glooko's platform, insulin pump data can be assessed for patterns that yield personalized recommendations.
With the new system, healthcare professionals are able to download patients' data from multiple devices and review reports during patient visits.
The package allows users to upload data from popular blood glucose meters, insulin pumps, and continuous glucose monitors (CGMs).
The feature adds on top of Glooko's support for over 30 blood glucose meters, popular activity trackers, and biometric monitors for blood pressure and weight.
The new capital will go towards expansion of the platform to include data from insulin pumps, continuous glucose monitoring systems and integration of predictive algorithms.
The company will include activity, weight and blood pressure data from a number of fitness trackers into its diabetes remote monitoring platform.